Webinar: Navigating the Saudi Market: Insights into Incentives and New Regulatory Frameworks
Event Date : 22-Jun-2025
In partnership with TOPRA, we’re excited to present an exclusive session by Pi Pharma Intelligence and HEPA Digital, focusing on critical topics shaping market access and regulatory developments in Saudi Arabia.
This session highlights the opportunities available for companies entering the Saudi market and offers guidance on aligning with its specific requirements. Key topics covered include:
- Latest Incentives for Accessing the Saudi Market.
- This session will provide valuable insights into the latest government initiatives and incentives designed to facilitate market access in Saudi Arabia. Learn about the opportunities and the strategies that can help pharmaceutical companies successfully enter and expand in the Saudi market.
- New Regulations Regarding Economic Evaluation Studies in the Saudi Market.
- Stay informed about the new regulations governing economic evaluation studies in Saudi Arabia. Our experts will guide you through the latest requirements and how these regulations influence market entry, product evaluation, and development strategies in the country.
Don’t miss out on this exclusive session, request the slides and session video

The Strategic Edge: Pi Pharma Intelligence's Role in Navigating MENA's Regulatory Landscape for Spain Introduction
Mar, 2024
Pi Pharma Intelligence is revolutionizing the way Spanish pharmaceutical companies approach the MENA market by providing a strategic edge in navigating its complex regulatory landscape.

Leveraging Predictive Analytics for Efficient Drug Supply Chains
Jan, 2025
Learn how implementing advanced data analytics can transform supply chain management, improve decision-making processes, and enhance overall operational performance in the pharmaceutical industry.

Transforming Drug Development Economics with AI-Driven Forecasting Models
May, 2024
This blog delves into the benefits of integrating artificial intelligence to enhance forecasting accuracy, efficiency, and scalability within the pharmaceutical industry.